PQUS0.870%
as of Oct 23
CI
GrowthTHE CIGNA GROUP
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes.
Close · 3M
+13.38%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals12
Win rate83% (10/12)
Avg buy return+4.41%
PQUS · Accumulation · 5d
weight 0.780% → 0.870% (+0.090 pp)·stock up 5.8% in the 30 days before
Oct 23·entry $306.95·now $306.95Fresh
0.00%
since Oct 23
PQUS · Accumulation · 5d
weight 0.780% → 0.890% (+0.110 pp)·stock up 12.5% in the 30 days before
Oct 22·entry $315.88·now $306.95Fresh
-2.83%
since Oct 22
PQUS · Weight increase · 4d
weight 0.780% → 0.860% (+0.080 pp)·stock up 10.2% in the 30 days before
Oct 20·entry $306.60·now $306.95Fresh
+0.11%
since Oct 20
PQUS · Weight increase · 3d
weight 0.780% → 0.850% (+0.070 pp)·stock up 7.0% in the 30 days before
Oct 16·entry $302.30·now $306.95Fresh
+1.54%
since Oct 16
PQUS · Weight increase · 2d
weight 0.780% → 0.830% (+0.050 pp)·stock up 4.4% in the 30 days before
Oct 15·entry $298.81·now $306.95Drifting
+2.72%
since Oct 15
PQUS · Weight increase · 3d
weight 0.750% → 0.780% (+0.030 pp)·stock up 1.2% in the 30 days before
Oct 8·entry $281.03·now $306.95Drifting
+9.22%
since Oct 8
PQUS · Weight increase · 2d
weight 0.750% → 0.770% (+0.020 pp)·stock down 0.8% in the 30 days before
Oct 7·entry $278.51·now $306.95Chased
+10.21%
since Oct 7
PQUS · Weight decrease · 3d
weight 0.850% → 0.810% (-0.040 pp)·stock down 3.1% in the 30 days before
Aug 29·entry $276.08·now $306.95
+11.18%
since Aug 29
PQUS · Weight decrease · 2d
weight 0.850% → 0.830% (-0.020 pp)·stock down 3.1% in the 30 days before
Aug 28·entry $278.88·now $306.95
+10.07%
since Aug 28
PQUS · Weight decrease · 2d
weight 0.640% → 0.620% (-0.020 pp)·stock down 6.7% in the 30 days before
Aug 13·entry $277.99·now $306.95
+10.42%
since Aug 13
PQUS · Weight increase · 2d
weight 0.250% → 0.640% (+0.390 pp)·stock down 3.2% in the 30 days before
Aug 8·entry $278.40·now $306.95Chased
+10.26%
since Aug 8
PQUS · Sudden change · 1d
weight 0.250% → 0.630% (+0.380 pp)·stock down 3.2% in the 30 days before
Aug 7·entry $282.49·now $306.95
+8.66%
since Aug 7
PQUS · Weight decrease · 2d
weight 0.320% → 0.290% (-0.030 pp)·stock up 0.7% in the 30 days before
Aug 2·entry $282.06·now $306.95
+8.82%
since Aug 2
PQUS · Weight increase · 2d
weight 0.290% → 0.310% (+0.020 pp)·stock up 3.6% in the 30 days before
Jul 26·entry $291.02·now $306.95Drifting
+5.47%
since Jul 26
PQUS · Weight decrease · 2d
weight 0.320% → 0.300% (-0.020 pp)·stock up 5.5% in the 30 days before
Jul 2·entry $287.77·now $306.95
+6.67%
since Jul 2
PQUS · Weight increase · 2d
weight 0.320% → 0.340% (+0.020 pp)·stock down 0.9% in the 30 days before
Jun 12·entry $298.00·now $306.95Drifting
+3.00%
since Jun 12
PQUS · Weight increase · 2d
weight 0.300% → 0.320% (+0.020 pp)·stock up 2.7% in the 30 days before
Jun 7·entry $289.61·now $306.95Drifting
+5.99%
since Jun 7
PQUS · New entry · 1d
weight 0 → 0.070% (new)·stock up 2.3% in the 30 days before
May 22·entry $286.24·now $306.95Drifting
+7.24%
since May 22
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
Too hard to callas of Oct 25
PQUS has been accumulating Cigna through mid-to-late October, lifting its weight from about 0.83% to 0.87% over several sessions, while QRFT holds a small 0.17% position. That buying conflicts with a Too Hard verdict, since the framework declines to underwrite the company at any price, though the AI's interest is consistent with a low P/E of 12.87 and a 15% ROE that look attractive on screens.
- Circle of CompetenceCigna's earnings depend on a PBM (Express Scripts) facing active regulatory and legislative threats to its rebate model, plus health-insurance medical-cost trends and policy swings, so ten-year unit economics cannot be projected with confidence.
- Economic Moat
- Management
- Financial Health
- Margin of Safety
Cigna looks cheap and reasonably profitable on headline numbers, but the framework first asks whether long-term earning power can be predicted, and pending PBM reform and medical-cost volatility make that doubtful. Because the circle of competence test fails, the moat, management, financial and price stages are not scored, and the verdict is Too Hard rather than a judgment on quality or value.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.